An NTD supersite of attack.

ABSTRACT: To date, most antibodies recognizing the SARS-CoV-2 spike (S) protein target the receptor binding domain (RBD). Three recent studies (Cerutti et al., 2021; McCallum et al., 2021; and Suryadevara et al., 2021) report on highly protective antibodies that are specific to the N-terminal domain (NTD) and target a conserved supersite.

SUBMITTER: Lok SM 

PROVIDER: S-EPMC8114578 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature